InvestorsObserver
×
News Home

Will Acasti Pharma Inc (ACST) Beat the Rest of the Stocks in the Healthcare Sector?

Thursday, December 30, 2021 11:13 AM | InvestorsObserver Analysts

Mentioned in this article

Will Acasti Pharma Inc (ACST) Beat the Rest of the Stocks in the Healthcare Sector?

Acasti Pharma Inc (ACST) is around the top of the Healthcare sector according to InvestorsObserver. ACST received an overall rating of 46, which means that it scores higher than 46% of stocks. Additionally, Acasti Pharma Inc scored a 89 in the Healthcare sector, ranking it higher than 89% of stocks in that sector.

Overall Score - 46
ACST has an Overall Score of 46. Find out what this means to you and get the rest of the rankings on ACST!

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. *Investors Observer* allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 46 would rank higher than 46 percent of all stocks. These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

What's Happening With Acasti Pharma Inc Stock Today?

Acasti Pharma Inc (ACST) stock is trading at $1.25 as of 11:13 AM on Thursday, Dec 30, of $0.00, or 0% from the previous closing price of $1.25. Volume today is low. So far 299,961 shares have traded compared to average volume of 2,634,055 shares. The stock has traded between $1.19 and $1.27 so far today. Click Here to get the full Stock Report for Acasti Pharma Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App